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Abstract — Objective: The goal of this work was to demonstrate 
technical feasibility of automated balloon pressure management 
during REBOA in the pre-clinical setting. Methods: This paper 
presents an intelligent balloon management device which automates 
the balloon inflation process, preventing the possibility of balloon 
over or under inflation, optimizes inflation pressure and if indicated, 
deflates automating partial REBOA to allow distal organ perfusion. 
Edwards TruWave pressure transducers are used to monitor the 
blood pressure proximal and distal to the balloon, as well as the 
internal balloon pressure. A faux PID controller, implemented on an 
Arduino platform, is used in a feedback control loop to allow a user 
defined mean arterial pressure setpoint to be reached, via a syringe 
driver which allows intelligent inflation and deflation of the catheter 
balloon. Results: Ex vivo testing on a vascular perfusion simulator 
provided the characteristic behavior of a fully occluded aorta, 
namely the decrease of distal pressure to zero. In vivo testing on live 
porcine models indicated that automated partial REBOA is 
achievable and by enabling partial occlusion may offer improved 
medical outcomes compared to manual control. Conclusion: 
Automated balloon pressure management of endovascular occlusion 
is feasible and can be successfully implemented without changes on 
current clinical workflows. Significance: With further development, 
automated balloon management may significantly improve clinical 
outcomes in REBOA.  
 
Index Terms—REBOA, balloon catheter, inflation, partial 
REBOA, feedback, automation, syringe, pressure  
 
I. BACKGROUND 
Non-compressible torso and junctional hemorrhage are a major 
cause of preventable death from trauma in both civilian and 
military populations [1]–[3]. These patients often present with 
profound hypotension and one method to emergently increase 
blood pressure to the heart and brain is to occlude the thoracic 
or proximal abdominal aorta.  This traditionally was  
accomplished through a thoracotomy or laparotomy and aortic 
cross-clamp. Emergency thoracotomy (ET) is a morbid 
procedure that carries a significant risk of occupational injury 
as well [4]. Resuscitative endovascular balloon occlusion of the 
aorta (REBOA) is a relatively new minimally invasive medical 
procedure in which a balloon catheter is inserted through the 
femoral artery, often percutaneously, and inflated within a 
patient’s thoracic or abdominal aorta (depending on injury 
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distribution) to occlude the aorta and sustain perfusion of 
critical organs (brain and heart). This was initially performed 
with off-the-shelf balloons approved for other uses, but more  
 
recently there are commercially available solutions such as the 
ER-REBOA catheter (Prytime Medical Devices Inc., Boerne, 
TX). This results in the same beneficial physiologic changes as 
ET, without the morbidity of a large chest or abdomen incision. 
Additionally, due to its minimal invasiveness, REBOA may be 
theoretically performed in the pre-hospital setting which would 
allow emergency personnel to stabilize a patient at the scene of 
the injury [5]. While this represents a major advancement in the 
treatment of the critically injured patient, prolonged aortic 
occlusion during transport and in-hospital resuscitation may 
result in deleterious effects due to distal organ ischemia and 
ischemia-reperfusion injury once the occlusion is removed. One 
possible solution is partial REBOA (pREBOA). pREBOA is 
performed by partially deflating the occluding balloon catheter 
to a diameter slightly less than that of the thoracic aorta, 
allowing a small amount of flow distal to the balloon to perfuse 
the visceral organs.  Ideally this would be timed so that mean-
arterial pressure to the head and heart were kept at a sufficient 
level while releasing as much blood flow distally as possible. 
The result would be a sustained increase in blood pressure to 
the brain and heart, while diminishing the ischemic insult to the 
bowel, kidneys, and liver. pREBOA has been demonstrated to 
be effective in a porcine model of hemorrhagic shock. Pigs that 
underwent pREBOA had significantly less ischemic injury to 
visceral organs, while still meeting proximal blood pressure 
goals, and had improved short-term survival [6]. Two major 
challenges exist however in the workflow of performing 
pREBOA, especially in the pre-hospital setting or far forward 
military trauma unit. Without the aid of fluoroscopy, it is 
difficult to determine the level of balloon insertion and over- or 
under-inflation may occur. While under-inflation results in an 
obvious non-response to treatment, over-inflation may rupture 
the balloon or the patient’s aorta, with catastrophic effects. 
Additionally, monitoring the inflation of the balloon to balance 
adequate proximal and distal pressures in pREBOA would be 
time consuming and impractical in this high-stress 
environment. Thus, a need exists to automate the proper 
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inflation of a REBOA balloon catheter to avoid over- or under-





The balloon catheter is inserted through a 14 Fr introducer 
sheath in the right external iliac artery and the balloon is 
positioned with the tip in the mid-descending thoracic aorta.  
Fluoroscopy is used for confirmation of the level of insertion. 
Additional introducer sheaths are placed for hemodynamic 
monitoring and resuscitation (for experimental phase only) as 
follows: 6Fr sheath in the left carotid artery with the tip in the 
aortic arch (for central aortic pressure), a 6Fr sheath in the left 
external iliac artery with the tip in the distal abdominal aorta 
(for distal aortic pressure), a 9Fr sheath in the right carotid 
artery with the tip in the aortic arch (for controlled hemorrhage), 
and a 9Fr sheath in the right jugular vein for resuscitation. The 
intelligent balloon management system (IBMS) is connected by 
luer lock to the side-port of the right iliac sheath, which 
provides distal pressure, and the wire lumen of the balloon 
catheter, which provides the proximal pressure. Proximal 
(above the balloon) and distal (below the balloon) blood 
pressures, as well as internal balloon pressure (saline) are 
monitored continuously by the IBMS. The user then inputs their 
desired minimum proximal mean arterial pressure (pMAP) into 
the IBMS user interface (UI). Mean arterial pressure (MAP) is 
calculated using real time measurements of systolic (SP), and 
diastolic pressure (DP) in (1). 
 
𝑀𝐴𝑃 =
(𝑆𝑃 + 2 ∗ 𝐷𝑃) 
3
             (1) 
This study uses MAP rather than SP as MAP may present a 
better overall blood understanding of blood flow and also serves 
as an indicator of perfusion pressure. The user selected 
proximal mean arterial pressure maintained by dynamic 
inflation and deflation of the balloon catheter within the aorta, 
which is achieved by controlling a stepper motor powered 
syringe driver to inflate the balloon to the required set point. If 
complete aortic occlusion results in a supra-therapeutic blood 
pressure (above the set-point), the IBMS deflates the balloon 
which results in partial occlusion, a lower proximal blood 
pressure, and blood flow to organs distal to the balloon. If 
complete occlusion results in a proximal blood pressure equal 
to or less than the set-point, the IBMS maintains full occlusion. 
 
 
Fig.1 – Indicative IBMS implementation showing partially occluded 
aorta allowing distal flow. 
Implementation 
1. Syringe Driver 
The syringe driver is based on the Open-Source Syringe Pump 
by Bas Wijnen, et al [7]. It is comprised of 3D printed and 
mechanical parts that are assembled by hand. The original parts, 
(gray), are made of polylactic acid. After assembly, 
modifications are made to the Body Holder parts, in order to fit 
a 60 mL/cc syringe. These modified parts (white) are made with 
acrylonitrile butadiene styrene. The fully assembled syringe 
driver is displayed in Figure 2.  
 
 
Fig.2 - Fully assembled 3D syringe driver w/ motor with 60ml syringe 
and locking component 
2. Motor Control 
The syringe driver is manipulated using a Nema17 65N stepper 
motor (Digikey Electronics) with a DRV8825 micro stepping 
motor driver (Texas Instruments Inc.) These are controlled via 
an Arduino UNO microcontroller. Motor movement is 
regulated using a faux PID controller based on an open-source 
configuration from Lake et al. [8]. This setup is implemented 
on the Arduino and is used to maintain the mean arterial 
pressure setpoint by inflating/deflating the balloon, in a 
feedback control loop as in Figure 3. 
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Fig.3- PID Control Diagram showing feedback signals. 
Manual PID tuning was performed until acceptable step and 
ramp responses were achieved. The parameter values used were 
as indicated in Table I.  
TABLE I 
PID CONTROLLER PARAMETERS 
Symbol Quantity Value 
Kp Proportional Gain 3000 
Ki Integral Gain 2.0
 
KD Derivative Gain 1.38 
Ts Sample Timing
 40 ms 
 
3. Pressure Sensing 
Feedback is provided by three separate pressure transducers 
(TruWave single adult pressure transducers, Edwards 
Lifesciences Corp.) which monitor pressure proximal to, distal 
to, and within the balloon. These sensors are inline fluid sensors 
designed for invasive blood pressure measuring. One valve is 
attached to the fluid line which is to be measured, with the 
second valve connected to a pressurized saline supply. Sensor 
specifications are given in Table II [9]. Initial ex vivo testing 
using MPX2100 inline pressure sensors (Freescale 
Semiconductor, Inc.) was abandoned for in vivo testing due to 
poor noise performance. 
TABLE II 
EDWARDS TRUWAVE PRESSURE SENSOR SPECIFICATIONS* 
Specification Value/Range 
Operating Pressure Range -50 to +300 mmHg 
Operating Temperature Range 15°C to 40°C 
Overpressure Tolerance -500 to +5000 mmHg 
Sensitivity 5.0µV/V/mmHg  
* At 6.00VDC and 25°C. 
 
INA122 operational amplifiers were used for sensor 
amplification. The gain equation for the amplifiers is given by 
(2) where RG = 560Ω resistors resulted in a gain value of 362 to 
utilize the full Arduino input range.  
 
                                        𝐺 = 5 +
200𝑘Ω
𝑅𝐺
                               (2) 
The sensors were calibrated in the required operating range of 
pressures, using a water column to provide varying height 
dependent values of head pressure. These experiments were 
repeated three times for each sensor to characterize variance. 
The sensor behavior was found to be highly linear, with 
incidental variance, indicating high reliability (see Figure 4). 
 
 
Fig.4 - Calibration graph for Edwards TrueWave Pressure 
Transducers. Calibrating pressures provided by water column, using 
head height as pressure variant 
4. System Implementation 
The full hardware setup for IBMS is shown in Figure 5.
 
Fig.5 - Full IBMS hardware setup showing (A) the syringe driver (B) 
amplifier board, (C) microcontroller and (D) 3 pressure transducers. 
5. Ex Vivo Testing 
Ex vivo testing was performed on a bench top pulsatile vascular 
system simulator provided by GEPROVAS (Strasbourg, 
France), a research facility which analyzes explanted 
cardiovascular prostheses [10]. 
 
 
Fig.6 – The GEPROVAS vascular simulator used for ex vivo testing of 
IBMS (www.geprovas.org). 
The GEPROVAS simulator (see Figure 6) allows flowrate and 
beats per minute to be altered, allowing multiple probable in 
vivo situations to be simulated. It is important to note that the 
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“aorta” in this model is hard plastic, with none of the expansion 
behavior witnessed in a real aorta. Of particular interest is the 
system response to full occlusion, which is the point at which 
the balloon is touching the internal walls of the flow pipe 
(simulated aorta). Constrained step and ramp tests (with the 
balloon inside the GEPROVAS aorta simulator) were 
performed to determine dynamic system performance, with 
these being compared to static unconstrained tests (balloon 
inflation on the open bench). The GEPROVAS system was 
initially set to provide 51 beats per minute, with a 71% PWM 
on/off stroke to replicate normal aortic conditioning during 
testing. 
 
6. In Vivo Testing 
Institutional Animal Ethics Committee approval was obtained 
in accordance with French regulations for in vivo non-survical 
porcine testing. Three female large white swine (sus scrofa) 
weighing 49-71kg were selected to undergo a controlled 
hemorrhage protocol based on the protocol described by 
Markov et. al [11] and pREBOA using the IBMS. The in vivo 
experiment had four study phases: (1) instrumentation delivery, 
(2) hemorrhage, (3) pREBOA, and (4) resuscitation. 
Physiologic parameters and hematologic laboratory values 
were obtained throughout the procedure. Each animal was 
euthanized at the conclusion of the resuscitation period. There 
were three animals in this, one for preliminary technology 
evaluation, followed by two for pre-clinical validation.  
 
The instrumentation phase included cannulation of an ear vein, 
induction of IV anesthesia using Propofol and Rocuronium 
followed by initiation of mechanical ventilation and inhaled 
anesthetic with isoflurane.  The bilateral common carotid 
arteries were then exposed along with the right internal jugular 
vein.  Next, the bilateral external iliac arteries were exposed.  
One hundred units/kg of intravenous unfractionated Heparin 
were then administered. A 14Fr vascular sheath was then 
introduced into the right external iliac artery, followed by a 6Fr 
vascular sheath in the left external iliac artery. Next, a 9Fr 
sheath was introduced under fluoroscopic guidance into the 
right common carotid artery with the tip in the aortic arch, and 
a 6Fr sheath was inserted into the left common carotid artery 
with the tip in the aortic arch. Finally, a 9Fr sheath was 
introduced into the right internal jugular vein for large volume 
resuscitation.  All sheaths were thoroughly flushed with 
heparinized saline to ensure patency throughout the procedure. 
The left carotid and external iliac artery sheaths were used to 
continuously monitor the proximal aortic and distal aortic 
pressures respectively. Monitoring the distal blood pressure via 
a femoral artery catheterization is standard practice in the 
management of major traumatic injuries once the patient has 
arrived to the hospital. 
 
Controlled hemorrhage to class IV shock (40% total blood 
volume loss) was achieved by gradual withdrawal of blood 
through the right carotid vascular sheath.  The rate was based 
on the protocol by White to simulate prehospital blood loss 
[12]. Based on a presumed volume of 66 ml/kg, 50% of the total 
blood loss was withdrawn in 7 minutes, and 50% in the 
following 13 minutes.  If MAP dropped below 25mmHg, 
hemorrhage was paused until the pressure stabilized. 
 
Once 40% of the total blood volume was withdrawn REBOA 
was initiated using the IBMS to control balloon inflation and 
deflation. The proximal pressure sensor was connected to the 
wire lumen of a 32mm Coda balloon catheter (Cook Medical, 
Bloomington, IN). The distal pressure sensor was connected to 
the side-port of the 14Fr right external iliac vascular sheath. The 
balloon pressure sensor was connected to the balloon inflation 
lumen of the catheter. The Coda balloon was then inserted 
through the 14Fr sheath and into the descending thoracic aorta 
under fluoroscopic guidance. A minimum proximal aortic MAP 
set-point of 60mmHg (commonly used as a minimal pressure in 
critical care settings for the seriously injured human patient) 
was entered into the IBMS and the pressure feedback system 
was activated. The balloon was observed during inflation under 
fluoroscopy and intermittently throughout the 60 minutes of 
automated REBOA. At the 60 minute mark, the balloon was 
manually deflated over 2 minutes with a pause if the pressure 
dropped below 40mmHg. Resuscitation was begun 
concomitantly with normal saline boluses until the pressure was 
maintained above 50 mmHg. After 60 minutes of resuscitation 
the protocol was ended and the animals were euthanized with 
potassium chloride. 
III. RESULTS 
1. Ex Vivo Results 
Ex vivo testing was performed for system characterization and 
tuning. Step and ramp test responses were gathered for 
constrained (within the dynamic flow vascular model) and 
unconstrained (balloon in free space) models using internal 
balloon pressure as the feedback signal, results of which are 
shown in Figure.7. 
 
Fig.7 - Step responses for constrained and unconstrained catheter 
balloon pressure under IBMS control. The damped nature of the 
control system is visible with roughly 15 second settling time. 
The unconstrained step response (red line) was shown to be 
strongly dampened with no overshoot. This behavior is required 
as over inflation of the balloon has to be avoided.  Inflation time 
from fully deflated to the required setpoint is less than 15 
seconds, and was limited by the motor stalling when being 
driven too hard. The constrained response was seen to have a 
slower settling time, and because of the dynamic pulsatile 
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nature of the system, some unavoidable oscillatory behavior is 
observed.  
 
Fig.8 - Ramp responses for constrained and unconstrained catheter 
balloon under IBMS control. Ramp tracking is shown to be accurate 
with a swift response time. Some degradation is seen when deflating, 
which seems to be related to dynamic pulsing on a semi inflated 
balloon. 
Ramp responses for constrained (red) and unconstrained (blue) 
tests  are remarkably similar, shown in Figure 8. Following the 
initial dead band region where a certain level of inflation is 
required to provide a feedback signal, the control system tracks 
the ramp setpoint with a high degree of accuracy. Some 
divergence from the setpoint ramp is seen in the initial deflation 
of the balloon in the constrained setting, likely caused by the 
increased effect of the pulsing fluid flow on a partially inflated 
balloon. The results of testing the systems behaviour for 
different levels of occlusion in the GEPROVAS vascular model 
are shown in Figure 9. 
 
Fig.9 - Ex vivo partial occlusion testing showing the effects of partial 
balloon inflation on proximal and distal pressure. Distal pressure can 
be seen decreasing but remains relatively high. 
For the ex vivo partial occlusion case, it is first important to note 
that significant distal pressure and flow can be seen when the 
proximal setpoint has been reached. Of particular interest is that 
the internal balloon pressure for a partial occlusion test lies 
between the levels of the proximal and distal pressures. 
 
Fig.10 - Ex vivo full occlusion testing showing the decay of distal 
pressure to zero as distal flow decreases and the spike in balloon 
pressure witnessed when the balloon fully blocks the simulated 
"aorta". 
In the above case, as the balloon inflates, the proximal pressure 
can be seen to rise to its physical limit, with the distal pressure 
decaying to zero as the flow is fully obstructed. A spike in 
balloon pressure can be seen around the 50 second mark, which 
seems to be an identifying feature of a fully occluded ex vivo 
“aorta”. A number of methods for identifying full occlusion 
therefore present themselves, including the point at which distal 
pressure decays to zero, the lack of increase in proximal 
pressure for increases in balloon pressure and the relative lack 
of effect that the pulsed flow has on a fully inflated balloon. 
 
2. In Vivo Results 
What follows are the results from the second in vivo 
experiment, on a 71 kg female pig following the protocols of 
Section II.6. A large animal was chosen to provide strong 
pressure signals throughout the experiment. 
 
Fig.11 - In vivo inflation period, focusing on the increase in proximal 
pressure to the user defined setpoint of 60 mmHg. Required setpoint is 
reached within 20 seconds, with the aorta remaining partially 
occluded. 
Figure 11 shows the intial inflation period to the required mean 
arterial setpoint of 60 mmHg, approximated by a mean 
proximal balloon pressure of 85 mmHg (~0.9V). The required 
setpoint was achieved within 20 seconds of initial inflation. 
Figure 11 corresponds to a partially occluded aorta. The noise 
associated with the internal balloon pressure signal is discussed 
in Section VI. In this study, fluoroscopy imaging of the aorta 
was used for confirmation when placing the uninflated balloon, 
and again following inflation of the balloon to the required 
setpoint, to confirm location. These images are shown in Figure 
12. 
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Fig.12 - Fluoroscopy images showing the initial placement of the 
deflated balloon. Right hand image shows partially inflated balloon, 
inflated by IBMS, which allows distal flow to perfuse through the body. 
The balloon was filled with a saline solution including a 
contrast media (Omnipaque, GE Healthcare Inc.), allowing it to 
be seen more clearly on the images. Figure 12(b) shows a 
partially occluded aorta with sufficient distal flow to prevent 
the negative effects which are associated with full occlusion. 
 
Fig.13 - Full in vivo data collection over 60 minutes, showing the 
IBMS reaction to animal self-regulation of blood pressure. 
The experiment continued for 60 minutes of partial REBOA. 
The sudden dip seen in the distal waveform (yellow) was 
caused by the erroneous closing of a flow valve. Of importance 
here is the reactive inflation and deflation of the balloon as it 
worked to maintain the required setpoint. Allowing for the 
noise on the internal balloon pressure signal, it can be seen that 
following initial inflation, the balloon deflated significantly as 
the animal self-regulated its blood pressure due to the partial 
occlusion of its aorta. As the experiment continued, the balloon 
again automatically inflated to maintain the proximal pressure 
value, as the animal began to suffer the effects of prolonged 
hemorrhagic shock. This is confirmed by a slight decrease in 
distal pressure, beginning around 2400 seconds. This behavior 
is indicative of the dynamic situation in which the IBMS device 
is required to operate. The temporary drop in distal pressure at 
1580 seconds in Figure 13 was due to inadvertent valve closure 
by an operator.   
IV. DISCUSSION 
This study shows that the Intelligent Balloon Management 
System can recognize a fully occluded aorta, ensuring that over 
inflation of an occluding balloon can be avoided. This was 
adequately characterized in the pre-clinical setting and 
demonstrated in vivo. Fully occlusive REBOA or partially 
occlusive pREBOA can be accurately and automatically 
maintained for a prolonged period of time. Controlled inflation 
and deflation cycles are performed using an open source syringe 
driver which can be easily replicated. The initial sensor used for 
the internal balloon pressure measurement was the MPX2100 
sensor, which was subsequently replaced by the Edwards 
TruWave pressure transducers for in vivo testing. The MPX 
sensors were significantly more prone to noise effects which 
accounts for the unexpectedly noisy waveforms shown in 
Figures 9 and 10 for ex vivo testing. The Edwards TruWave 
pressure transducers require in-line pressurized saline supply 
(saline bag pressurized to 300 mmHg) to function correctly, 
which may not be available in the pre-hospital setting. Issues 
surrounding accurate calibration for mean arterial pressure 
reading also require further attention, as well as an optimally 
packaged hardware setup to minimize risk of electromagnetic 
interference from the stepper motor affecting the system 
pressure readings. Also, the effect of saline/contrast agent 
admixture viscosity on set-point tracking response could be 
addressed at calibration by specifying the preferred 
contrast/saline ratio for use. Future system characterization 
should investigate whether the user interface should facilitate 
specification of mean arterial (or systolic) pressure goal, or 
percentage occlusion (90% occlusion being almost fully 
occluded, 50 % occlusion allowing significant distal blood 
flow). Even in the absence of a wire-guide, minimal distal 
migration of the balloon was observed during full and partial 
inflation. Migration was also inhibited by firmly fixing the 
catheter at the groin. The 32mm balloon and 12Fr sheath 
combination used in this study represents a common approach 
in current REBOA practice although future work might seek to 
validate accurate distal pressure measurement with a smaller 
sheath, ideally one which facilitates manual compression on 
removal. While the current study demonstrated adequate 
response with the Cook Coda balloon, future investigations may 
benefit from the development of a customized pREBOA 
specific balloon catheter to improve the ease and speed with 
which the system can be set up and powered on. Any final 
balloon design should incorporate integrated proximal and 
balloon pressure monitoring within the balloon catheter, and the 
blood pressure may be monitored from the femoral introducer 
sheath. Such a system may enable the surgeon to program either 
systolic or MAP set-points during treatment.  In the current 
protocol, the balloon was placed above the diaphragm, and 
below the aortic arch, as validated by fluoroscopic imaging. 
Future work may alleviate or eliminate dependence on 
radiological imaging through the use of electromagnetic 
tracking [13] or ultrasound [14]. Future work is also required to 
improve the accuracy of pressure readings, the mobility and 
usability of the device and to eliminate fluroscopy as a 
confirmation method. Finally, while the current study 
demonstrated adequate response with the Cook Coda balloon, 
future investigations may benefit from the development of a 
customized pREBOA specific balloon catheter to improve the 
ease and speed with which the system can be set up and 
powered on. Any final balloon design should incorporate 
integrated proximal and balloon pressure monitoring within the 
balloon catheter, and the blood pressure may be monitored from 
the femoral introducer sheath. Such a system may enable the 
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surgeon to program either systolic or MAP set-points during 
treatment.  In the current protocol, the balloon was placed above 
the diaphragm, and below the aortic arch, as validated by 
fluoroscopic imaging. 
V. CONCLUSION 
This is the first report of a fully automated system for 
controlling partial and complete endovascular occlusion of the 
aorta. The intelligent balloon management system maintained a 
user defined proximal arterial pressure for partial REBOA and 
can recognise a fully occuluded aorta in-vivo, preventing over 
inflation of the balloon. The feasibility of automated partial 
REBOA is clinically significant as it may decrease patient 
recovery time by continuing blood circulation to the lower 
limbs while maintaining adequate pressure to the brain. 
Additional pre-clinical validation studies are required to 
confirm safety and reliability. However, the study provides 
compelling validation of the proof-of-concept prototype.   
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